Tech Company Financing Transactions

CardioMEMS Funding Round

Aperture Venture Partners, Arcapita Ventures and Boston Millennia Partners participated in a $33 million Series E venture round for CardioMEMS. This venture round was announced by the company on 12/5/2007.

Transaction Overview

Company Name
Announced On
12/5/2007
Transaction Type
Venture Equity
Amount
$33,000,000
Round
Series E
Proceeds Purpose
Jay Yadav, MD, Chairman and CEO of CardioMEMS, Inc. said, "This is a very exciting time for CardioMEMS as we conduct our randomized trial aimed at reducing heart failure hospitalizations with our wireless sensing technology. The absence of leads and batteries in our technology, we believe, provides a substantial safety advantage."

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
387 Technology Cir. NW 500
Atlanta, MN 30313
USA
Email Address
Overview
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide.
Profile
CardioMEMS LinkedIn Company Profile
Social Media
CardioMEMS Company Twitter Account
Company News
CardioMEMS News
Facebook
CardioMEMS on Facebook
YouTube
CardioMEMS on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Starks
  Daniel Starks LinkedIn Profile  Daniel Starks Twitter Account  Daniel Starks News  Daniel Starks on Facebook
Chief Marketing Officer
Lisa Andrade
  Lisa Andrade LinkedIn Profile  Lisa Andrade Twitter Account  Lisa Andrade News  Lisa Andrade on Facebook
Chief Operating Officer
Michael Rousseau
  Michael Rousseau LinkedIn Profile  Michael Rousseau Twitter Account  Michael Rousseau News  Michael Rousseau on Facebook
Executive Vice President
John Heinmiller
  John Heinmiller LinkedIn Profile  John Heinmiller Twitter Account  John Heinmiller News  John Heinmiller on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/5/2007: Verical venture capital transaction
Next: 12/5/2007: OPX Biotechnologies venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary